Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Nab-Paclitaxel, Carboplatin and Thoracic Radiotherapy in Local Advanced Squamous Cell Lung Cancer
NCT01494415Phase 2Unknown
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jul 2012
- Primary completion
- Jul 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in squamous cell carcinoma of the lung (LSCC), sponsored by Hangzhou First People's Hospital. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT01494415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494415.